Hubei Kailong Chemical Group Co., Ltd. (SHE:002783)
China · Delayed Price · Currency is CNY 9.08
+0.07 (0.78%)
Apr 29, 2026, 3:04 PM CST
SHE:002783 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 3,544 | 3,640 | 3,749 | 3,365 | 2,716 |
Other Revenue | - | 46.5 | 30.04 | 41.16 | 43.75 |
| 3,544 | 3,686 | 3,779 | 3,406 | 2,759 | |
Revenue Growth (YoY) | -3.85% | -2.45% | 10.95% | 23.44% | 37.21% |
Cost of Revenue | 2,472 | 2,619 | 2,762 | 2,605 | 2,134 |
Gross Profit | 1,072 | 1,067 | 1,017 | 800.54 | 625.37 |
Selling, General & Admin | 510.79 | 524.22 | 439.42 | 384.39 | 397.59 |
Research & Development | 98.39 | 86.89 | 79.95 | 66.37 | 44.78 |
Other Operating Expenses | 18.67 | 20.27 | 34.95 | 31.14 | 36.55 |
Operating Expenses | 627.84 | 630.93 | 564.63 | 493.02 | 494.44 |
Operating Income | 444.55 | 435.93 | 451.98 | 307.51 | 130.93 |
Interest Expense | - | -109.75 | -135.19 | -136.25 | -122.66 |
Interest & Investment Income | 17.04 | 68.54 | 20.37 | 6.24 | 4.49 |
Currency Exchange Gain (Loss) | - | 0.02 | -3.2 | -2.78 | 0.01 |
Other Non Operating Income (Expenses) | -75.26 | -15.82 | -22.79 | -8.96 | -4.23 |
EBT Excluding Unusual Items | 386.32 | 378.92 | 311.16 | 165.76 | 8.54 |
Impairment of Goodwill | - | -2.55 | - | -50.77 | -333.84 |
Gain (Loss) on Sale of Investments | 0.01 | - | - | - | -62.44 |
Gain (Loss) on Sale of Assets | 0.5 | -15.92 | 10.31 | 51.99 | -6.6 |
Asset Writedown | -33.04 | -40.61 | -21.16 | -12.15 | -90.97 |
Other Unusual Items | - | -29.05 | 2.52 | 34.07 | -0.27 |
Pretax Income | 353.79 | 290.79 | 302.83 | 188.89 | -485.58 |
Income Tax Expense | 106.66 | 34.27 | 55.89 | 33.21 | -14.06 |
Earnings From Continuing Operations | 247.14 | 256.52 | 246.95 | 155.68 | -471.52 |
Minority Interest in Earnings | -104.72 | -108.36 | -71.6 | -22.34 | 76.83 |
Net Income | 142.42 | 148.16 | 175.35 | 133.33 | -394.69 |
Net Income to Common | 142.42 | 148.16 | 175.35 | 133.33 | -394.69 |
Net Income Growth | -3.87% | -15.51% | 31.51% | - | - |
Shares Outstanding (Basic) | 491 | 463 | 390 | 381 | 369 |
Shares Outstanding (Diluted) | 491 | 463 | 390 | 381 | 369 |
Shares Change (YoY) | 6.07% | 18.82% | 2.29% | 3.28% | -4.75% |
EPS (Basic) | 0.29 | 0.32 | 0.45 | 0.35 | -1.07 |
EPS (Diluted) | 0.29 | 0.32 | 0.45 | 0.35 | -1.07 |
EPS Growth | -9.38% | -28.89% | 28.57% | - | - |
Free Cash Flow | 374.08 | 193.15 | 4.57 | 28.2 | -249.02 |
Free Cash Flow Per Share | 0.76 | 0.42 | 0.01 | 0.07 | -0.68 |
Dividend Per Share | - | 0.100 | 0.100 | 0.100 | - |
Gross Margin | 30.26% | 28.94% | 26.90% | 23.50% | 22.66% |
Operating Margin | 12.54% | 11.83% | 11.96% | 9.03% | 4.75% |
Profit Margin | 4.02% | 4.02% | 4.64% | 3.91% | -14.30% |
Free Cash Flow Margin | 10.55% | 5.24% | 0.12% | 0.83% | -9.03% |
EBITDA | 806.01 | 777.06 | 788.29 | 594.21 | 427.9 |
EBITDA Margin | 22.74% | 21.08% | 20.86% | 17.45% | 15.51% |
D&A For EBITDA | 361.46 | 341.13 | 336.31 | 286.7 | 296.97 |
EBIT | 444.55 | 435.93 | 451.98 | 307.51 | 130.93 |
EBIT Margin | 12.54% | 11.83% | 11.96% | 9.03% | 4.75% |
Effective Tax Rate | 30.15% | 11.79% | 18.45% | 17.58% | - |
Revenue as Reported | - | 3,686 | 3,779 | 3,406 | 2,759 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.